Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Basel Medical (BMGL) over the last 3 years, with Q2 2025 value amounting to $2.3 million.

  • Basel Medical's Cash & Equivalents rose 5870.66% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 5870.66%. This contributed to the annual value of $2.3 million for FY2025, which is 6242.07% up from last year.
  • Basel Medical's Cash & Equivalents amounted to $2.3 million in Q2 2025, which was up 5870.66% from $5.4 million recorded in Q4 2024.
  • Over the past 5 years, Basel Medical's Cash & Equivalents peaked at $5.4 million during Q4 2024, and registered a low of $901754.5 during Q4 2023.
  • Over the past 3 years, Basel Medical's median Cash & Equivalents value was $1.9 million (recorded in 2025), while the average stood at $2.5 million.
  • As far as peak fluctuations go, Basel Medical's Cash & Equivalents surged by 50436.35% in 2024, and later soared by 5870.66% in 2025.
  • Quarter analysis of 3 years shows Basel Medical's Cash & Equivalents stood at $901754.5 in 2023, then skyrocketed by 504.36% to $5.4 million in 2024, then crashed by 58.01% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q2 2025, $5.4 million for Q4 2024, and $1.4 million during Q2 2024.